Trade Summary

1 week ago, Inrig Jula, serving as Chief Medical Officer at Travere Therapeutics, Inc. (TVTX), sold 15,000 shares at $42.00 per share, for a total transaction value of $630,005.00. Following this transaction, Inrig Jula now holds 88,787 shares of TVTX.

This sale represents a 14.00% decrease in Inrig Jula's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, December 24, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 5 days after the trade was made.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.